Citizens Raises Papzimeos Sales Forecast After Precigen’s Q3 Topline Beat – Sees 142% Upside Potential In PGEN Stock
Citizens raised its Q4 sales forecast for Papzimeos to $88 million from $65 million.
Citizens raised its Q4 sales forecast for Papzimeos to $88 million from $65 million.